肿瘤患者合并非白念珠菌性血流感染的危险因素分析

发布时间：2018-09-09 16:17

【摘要】：目的分析非白念珠菌性血流感染的流行病学现况及相关危险因素,为临床防治提供依据。方法对2007-2015年医院91例念珠菌性血流感染肿瘤患者病历资料进行回顾性分析。结果 91例念珠菌性血流感染肿瘤患者中白念珠菌性血流感染者49例占53.8%,非白念珠菌感染者42例占46.2%,其中造成非白念珠菌性血流感染的病原菌依次为近平滑念珠菌21株占23.1%,光滑念珠菌8株占8.8%、热带念珠菌7株占7.7%、无名念珠菌和葡萄牙念珠菌各3株占3.3%;念珠菌性血流感染患者30天死亡率为28.6%(白念珠菌为26.5%,非白念珠菌为31.0%);相比白念珠菌,住院天数≥35天,以及肿瘤远处脏器转移是非白念珠菌性血流感染的独立危险因素。结论本研究不仅对念珠菌性血流感染流行病学现况进行了分析,更明确了肿瘤患者合并非白念珠菌性血流感染的独立危险因素,为制定相应的预防及治疗措施提供了理论依据。
[Abstract]:Objective to analyze the epidemiological status and related risk factors of non-Candida albicans blood flow infection in order to provide evidence for clinical prevention and treatment. Methods the medical records of 91 patients with Candida bloodstream infection tumor from 2007 to 2015 were analyzed retrospectively. Results among 91 patients with Candida hemodynamic infection tumor, 49 cases (53.8%) were infected with candida albicans and 42 cases (46.2%) were infected with non-candida albicans. 21 strains accounted for 23.1m, 8 strains for Candida smoothing, 7.7m for Candida tropicalis, 3 strains for unnamed candida and 3 strains for Portuguese candida. The 30-day mortality rate of patients with candidiasis was 28.6% (26.5% for Candida albicans and 31.0% for non-candida albicans), compared with Candida albicans, Candida albicans, The days of hospitalization 鈮，

本文编号：2232907